This observation demonstrated that BRD4 regulated the tumor growth in breast cancer cells with wild-type p53 through mechanisms other than p53/p21 signaling, such as enhancer activation and gene transcription of c-Myc and estrogen receptor [36,37], which needs to be further investigated. Here, CDKN1A is linked to breast carcinoma.